Skip to main content

Walbert Timothy P's Form 4 filing

Horizon Therapeutics Public Ltd Co (HZNP) · filed Feb 11, 2022

Accession no.
0001209191-22-008838
Filed
Feb 11, 2022
Trade date
Feb 11, 2022
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.44M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Walbert Timothy PCIK 0001349376Director, Officer (Chairman, President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 11, 2022Ordinary SharesMOption exerciseAcquired+25,000$22.14+$553,500610,549Direct
Feb 11, 2022Ordinary SharesSSaleDisposed−19,663$97.32−$1,913,603.16590,886Direct
Feb 11, 2022Ordinary SharesSSaleDisposed−5,337$97.74−$521,638.38585,549Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 11, 2022Ordinary SharesMOption exerciseDisposed−25,000$0.00$0942,565Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)